Planegg, Germany

Ulrich Essig

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1991-2018

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovations of Ulrich Essig: A Pioneer in Antibody Development

Introduction

Ulrich Essig, an accomplished inventor based in Planegg, Germany, has made significant contributions to the field of immunology, particularly in the development of innovative antibodies. With a remarkable portfolio of 11 patents, Essig is recognized for his expertise in creating solutions that enhance immunoassay techniques and drug antibody assays.

Latest Patents

Among Essig’s notable inventions are two groundbreaking patents. The first patent focuses on "Non-cross-reactive anti-IgG antibodies," which describes cell lines DSM ACC3006, DSM ACC3007, and DSM ACC3008. This patent details antibodies derived from these cell lines that bind specifically to human or chimpanzee IgG, while exhibiting no binding to canine and marmoset IgG. Moreover, it includes antibodies that specifically target an IgG1 comprising a kappa light chain constant domain, significantly advancing immunoassay methodologies.

The second patent, titled "Anti-drug antibody assay," involves an antibody that specifically binds to Cynomolgus IgG, characterized by its non-binding property to Human IgG. This invention presents a method for the immunological determination of immune complexes (DA/ADA complexes) involving drug antibodies and anti-drug antibodies within samples of a monkey species through a double antigen bridging immunoassay.

Career Highlights

Ulrich Essig has built an impressive career, having worked with renowned companies such as Boehringer Mannheim GmbH and Hoffmann-La Roche Inc. His work at these institutions has significantly influenced the development of antibody-based assays, reinforcing his status as a leading figure in immunology.

Collaborations

Throughout his career, Essig has collaborated with notable professionals in the field. Among his coworkers are Rudolf Vogel and Christa Hubner-Parajsz, who have contributed to his research and development efforts. These collaborations have allowed for the pooling of knowledge and expertise, ultimately leading to innovative advancements in antibody technology.

Conclusion

Ulrich Essig's dedication to innovation in the realm of antibodies has resulted in significant advancements that hold promise for future applications in immunology. His numerous patents serve as a testament to his inventiveness and commitment to improving diagnostic methodologies. As the scientific community continues to evolve, the contributions of inventors like Essig will be pivotal in shaping the future of healthcare and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…